1
|
Geraghty R, Pietropaolo A, Tzelves L, Lombardo R, Jung H, Neisius A, Petrik A, Somani BK, Davis NF, Gambaro G, Boissier R, Skolarikos A, Tailly T. Which Measure of Stone Burden is the Best Predictor of Interventional Outcomes in Urolithiasis: A Systematic Review and Meta-analysis by the YAU Urolithiasis Working Group and EAU Urolithiasis Guidelines Panel. EUR UROL SUPPL 2025; 71:22-30. [PMID: 39651399 PMCID: PMC11625283 DOI: 10.1016/j.euros.2024.10.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/27/2024] [Indexed: 12/11/2024] Open
Abstract
Background and objective Stone size has traditionally been measured in one dimension. This is reflected in most of the literature and in the EAU guidelines. However, recent studies have shown that multidimensional measures provide better prediction of outcomes. Methods We performed a systematic review and meta-analysis of the prognostic accuracy of measures of stone size (PROSPERO reference CRD42022346967). We considered all studies reporting prognostic accuracy statistics on any intervention for kidney stones (extracorporeal shockwave lithotripsy [ESWL], ureterorenoscopy [URS], or percutaneous nephrolithotomy [PCNL]; Population) using multiplane measurements of stone burden (area in mm2 or volume in mm3; Intervention) in comparison to single-plane measurements of stone burden (size in mm; Intervention) for the study-defined stone-free rate (Outcome) in a PICO-framed question. We also assessed complication rates (overall and by Clavien-Dindo grade) and the operative time as secondary outcomes. Searches were made between 1970 and August 2023. We used the DeLong method to compare receiver operating characteristic (ROC) curves. Key findings and limitations Of 24 studies included in the review, 12 were eligible for comparative analysis with the DeLong test following meta-analysis of prognostic accuracy. For prediction of stone-free status, the area under the ROC curve (AUC) was significantly higher for stone volume than for stone size (0.71 vs 0.67; p < 0.001). Subanalyses confirmed this for ESWL and URS, but not for PCNL. For URS, the AUC was also significantly higher for stone area than for stone size (0.79 vs 0.77; p < 0.001). Throughout all analyses, there was no difference in AUC between stone area and stone volume. There was high risk of bias for all analyses apart from the URS subanalyses. Conclusions and clinical implications According to the limited data currently available, stone-free rates are predicted with significantly higher accuracy using multidimensional measures of stone burden in comparison to a single linear measurement. Patient summary We reviewed different ways of measuring the size of stones in the kidney or urinary tract and compared their accuracy in predicting stone-free rates after treatment. We found that measurement of the stone area (2 dimensions) or stone volume (3 dimensions) is better than stone diameter (1 dimension) in predicting stone-free status after treatment.
Collapse
Affiliation(s)
- Robert Geraghty
- Department of Urology, Freeman Hospital, Newcastle-upon-Tyne, UK
- Urolithiasis Guidelines Panel, European Association of Urology, Arnhem, The Netherlands
| | - Amelia Pietropaolo
- Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK
- Young Academic Urologists Urolithiasis Working Group, European Association of Urology, Arnhem, The Netherlands
| | - Lazaros Tzelves
- Urolithiasis Guidelines Panel, European Association of Urology, Arnhem, The Netherlands
- Young Academic Urologists Urolithiasis Working Group, European Association of Urology, Arnhem, The Netherlands
- Department of Urology, National and Kapodistrian University of Athens, Sismanogleio Hospital, Athens, Greece
| | - Riccardo Lombardo
- Urolithiasis Guidelines Panel, European Association of Urology, Arnhem, The Netherlands
- Sant’Andrea Hospital, Sapienza University, Rome, Italy
| | - Helene Jung
- Urolithiasis Guidelines Panel, European Association of Urology, Arnhem, The Netherlands
- Department of Urology, University of Southern Denmark, Odense, Denmark
| | - Andreas Neisius
- Urolithiasis Guidelines Panel, European Association of Urology, Arnhem, The Netherlands
- Department of Urology, Bruederkrankenhaus Trier, Johannes Gutenberg University Mainz, Trier, Germany
| | - Ales Petrik
- Urolithiasis Guidelines Panel, European Association of Urology, Arnhem, The Netherlands
- Department of Urology, First Faculty of Medicine, Charles University, Prague, Czechia
| | - Bhaskar K. Somani
- Urolithiasis Guidelines Panel, European Association of Urology, Arnhem, The Netherlands
- Department of Urology, University Hospital Southampton NHS Foundation Trust, Southampton, UK
| | - Niall F. Davis
- Urolithiasis Guidelines Panel, European Association of Urology, Arnhem, The Netherlands
- Department of Urology, Beaumont Hospital, Dublin, Ireland
- Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland
| | - Giovanni Gambaro
- Urolithiasis Guidelines Panel, European Association of Urology, Arnhem, The Netherlands
- Division of Nephrology and Dialysis, Department of Medicine, University of Verona, Verona, Italy
| | - Romain Boissier
- Young Academic Urologists Urolithiasis Working Group, European Association of Urology, Arnhem, The Netherlands
- Department of Urology and Renal Transplantation, Aix-Marseille University, Marseille, France
| | - Andreas Skolarikos
- Urolithiasis Guidelines Panel, European Association of Urology, Arnhem, The Netherlands
- Department of Urology, National and Kapodistrian University of Athens, Sismanogleio Hospital, Athens, Greece
| | - Thomas Tailly
- Urolithiasis Guidelines Panel, European Association of Urology, Arnhem, The Netherlands
- Young Academic Urologists Urolithiasis Working Group, European Association of Urology, Arnhem, The Netherlands
- Department of Urology, University Hospital of Ghent, Ghent, Belgium
| |
Collapse
|
2
|
Tobe T, Inoue T, Yamamichi F, Tominaga K, Fujita M, Fujisawa M, Miyake H. Predictive factors for prolonged operative time in ureteroscopic lithotripsy for ureteral stones A retrospective cohort study. Can Urol Assoc J 2024; 18:E261-E268. [PMID: 39190171 PMCID: PMC11404684 DOI: 10.5489/cuaj.8713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/28/2024]
Abstract
INTRODUCTION A prolonged operative time of lithotripsy with ureteroscopy for urolithiasis increases the risk of infectious complications; however, few reports have investigated the factors prolonging the operative time for ureteral stones. We investigated the factors associated with longer operative time in ureteroscopy for ureteral stones. METHODS This retrospective cohort study analyzed patients who underwent retrograde ureteroscopic lithotripsy for ureteral stones and achieved an endoscopic stone-free status between April 2019 and July 2022. Patients were classified into two groups based on an operative time of ≥90 minutes or <90 minutes. We compared the patient and stone characteristics and surgical outcomes, and investigated the factors associated with a prolonged operative time. RESULTS The cohort comprised 519 patients, with 58 patients in the group with an operative time of ≥90 minutes. Compared to the shorter operative time group, the longer operative time group had a significantly greater proportion of males, stone diameter, stone volume, and Hounsfield units of stone; additionally, the longer operative time group had higher prevalences of endoscopic findings of edema, polyps, and mucosa-stone adherence. Multivariable analysis showed that stone size >10 mm (odds ratio 4.05), polyps (odds ratio 2.40), and mucosal adherence (odds ratio 3.51) were significantly associated with an operative time exceeding 90 minutes. There were no significant differences between the two groups in the incidences of postoperative fever and systemic inflammatory response syndrome. CONCLUSIONS Stone size, endoscopic findings of polyps, and mucosa-stone adherence were independent factors associated with a longer operative time.
Collapse
Affiliation(s)
- Taisuke Tobe
- Department of Urology, Kobe University Graduate School of Medicine, Hyogo, Japan
| | - Takaaki Inoue
- Department of Urology, Kobe University Graduate School of Medicine, Hyogo, Japan
- Department of Urology and Stone Center, Hara Genitourinary Hospital, Hyogo, Japan
| | - Fukashi Yamamichi
- Department of Urology and Stone Center, Hara Genitourinary Hospital, Hyogo, Japan
| | - Koki Tominaga
- Department of Urology, St. Luke's International Hospital, Tokyo, Japan
| | - Masaichiro Fujita
- Department of Urology and Stone Center, Hara Genitourinary Hospital, Hyogo, Japan
| | - Masato Fujisawa
- Department of Urology, Kobe University Graduate School of Medicine, Hyogo, Japan
| | - Hideaki Miyake
- Department of Urology, Kobe University Graduate School of Medicine, Hyogo, Japan
| |
Collapse
|
3
|
Huang R, Chen JC, Zhou YQ, Wang JJ, Hui CC, Jiang MJ, Xu C. Relocation of lower pole renal stones helps improve the stone-free rate during flexible ureteroscopy with a low complication rate. World J Urol 2024; 42:30. [PMID: 38217719 PMCID: PMC10787685 DOI: 10.1007/s00345-023-04703-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2023] [Accepted: 09/06/2023] [Indexed: 01/15/2024] Open
Abstract
OBJECTIVE To compare the efficacy and safety of relocating the lower pole stones to a favorable pole during flexible ureteroscopy with in situ lithotripsy for the treatment of 10-20 mm lower pole stone (LPS). METHODS This study was a prospective analysis of patient outcomes who underwent an FURS procedure for the treatment of 10-20 mm lower pole renal stones from January 2020 to November 2022. The patients were randomized into a relocation group or in situ group. The LPSs were relocated into a calyx, during lithotripsy in the relocation group was performed, whereas the in situ group underwent FURS without relocation. All the procedures were performed by the same surgeon. The patients' demographic data, stone characteristics, perioperative parameters and outcomes, stone-free rate (SFR), complications, and overall costs were assessed retrospectively. RESULTS A total of 90 patients were enrolled and analyzed in this study (45 per group) with no significant differences between the two groups in terms of age, gender, BMI, diabetes, hypertension, stone size, number, laterality, composition, and density. The mean operation time, total energy consumption, postoperative stay, and complications were similar between the groups. Both groups had similar SFR at 1 day postoperative follow-up (p = 0.091), while the relocation group achieved significantly higher SFR 3 months later (97.8% vs 84.4%, p = 0.026). The relocation group also had a significantly higher WisQol score than the in situ group (126.98 vs 110.18, p < 0.001). CONCLUSION A satisfactory SFR with a relatively low complication rate was achieved by the relocation technique during the FURS procedure.
Collapse
Affiliation(s)
- Ru Huang
- Department of Urology, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215200, China
| | - Jian-Chun Chen
- Department of Urology, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215200, China
| | - Yong-Qiang Zhou
- Department of Urology, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215200, China
| | - Jin-Jin Wang
- Department of Radiology, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215200, China
| | - Chu-Chu Hui
- Department of Ultrasound, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215200, China
| | - Min-Jun Jiang
- Department of Urology, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215200, China.
| | - Chen Xu
- Department of Urology, Suzhou Ninth Hospital Affiliated to Soochow University, Suzhou, 215200, China.
| |
Collapse
|
4
|
Kronenberg P, Cerrato C, Juliebø-Jones P, Herrmann T, Tokas T, Somani BK. Advances in lasers for the minimally invasive treatment of upper and lower urinary tract conditions: a systematic review. World J Urol 2023; 41:3817-3827. [PMID: 37906263 DOI: 10.1007/s00345-023-04669-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2023] [Accepted: 09/26/2023] [Indexed: 11/02/2023] Open
Abstract
PURPOSE Technological advancements in laser lithotripsy are expanding into numerous fields of urology, like ureteroscopy (URS), percutaneous nephrolithotomy (PCNL), and benign and malignant soft-tissue treatments. Since the amount of research regarding lasers in urology has grown exponentially, we present a systematic review of the most recent and relevant advances encompassing all lasers used in urological endoscopic treatment. METHODS We performed a literature search using PubMed (May 2023) to obtain information about lasers for urological purposes. We included only recent data from published articles between 2021 and 2023 or articles ahead of print. RESULTS Lasers are widely used in lithotripsy for ureteric, renal, and bladder stones, benign prostate surgery, and bladder and upper tract tumor ablation. While the holmium (Ho:YAG) laser is still predominant, there seems to be more emphasis on pulse modulation and newer lasers such as thulium fiber laser (TFL) and pulsed Tm:YAG laser. CONCLUSION The use of lasers and related technological innovations have shown increasing versatility, and over time have proven to be invaluable in the management of stone lithotripsy, treatment of benign and malignant prostate diseases, and urothelial tumors. Laser endoscopic treatment is heavily based on technological nuances, and it is essential to know at least the basics of these technologies. Ultimately the choice of laser used depends on its availability, cost, surgeon experience and expertise.
Collapse
Affiliation(s)
| | - Clara Cerrato
- University Hospital Southampton NHS Trust, Southampton, UK
| | | | - Thomas Herrmann
- Department of Urology, Kantonspital Frauenfeld, Spital Thurgau AG, Frauenfeld, Switzerland
- Training and Research in Urological Surgery and Technology (T.R.U.S.T.)-Group, Hall in Tirol, Austria
| | - Theodoros Tokas
- Training and Research in Urological Surgery and Technology (T.R.U.S.T.)-Group, Hall in Tirol, Austria
- Department of Urology, Medical School, University General Hospital of Heraklion, University of Crete, Heraklion, Greece
| | | |
Collapse
|